Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Ruxolitinib
Ruxolitinib
941678-49-5
|
306.159
|
2.177
Ruxolitinib is an antineoplastic agent that inhibits cell proliferation, induces apoptosis of malignant cells, and reduces pro-inflammatory cytokine plasma levels by inhibiting JAK-induced phosphorylation of signal transducer and activator of transcription (STAT). It is used to treat various types of myelofibrosis, polycythemia vera.
(R)-ruxolitinib | INCB018424 | Rux | jakafi | ruxolitinib
Ruxolitinib is an antineoplastic agent that inhibits cell proliferation, induces apoptosis of malignant cells, and reduces pro-inflammatory cytokine plasma levels by inhibiting JAK-induced phosphorylation of signal transducer and activator of transcription (STAT). It is used to treat various types of myelofibrosis, polycythemia vera.
(R)-ruxolitinib | INCB018424 | Rux | jakafi | ruxolitinib
$81/5 mg
(EBC)
1
We provide 0 compound for Ruxolitinib